75F40125P00116

PROTEOMIC ANALYSIS OF CANCER PATIENT PLASMA SAMPLES

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	FDA OFFICE OF ACQ GRANT SVCS
NAICS	541720 — Research and Development in the Social Sciences and Humanities
PSC	B529 — Scientific Data Studies
Parent award / vehicle	Not reported
Set-aside	NO SET ASIDE USED.
Pricing type	FIRM FIXED PRICE
Obligations	$106.7K
Current contract value	$106.7K
Potential contract value / ceiling	$106.7K
Start date	Jul 22, 2025
Current end date	Jul 31, 2026
Potential end date	Jul 31, 2026
Latest award activity	Jul 14, 2026
Source loaded	Sep 26, 2026

Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Jul 14, 2026	P00002	$0	EO 14398-THE PURPOSE OF THIS MODIFICATION IS TO ATTACH THE OLINK ANALYSIS SERVICES AGREEMENT TO THE CONTRACT, AND INCORPORATE FAR 52.222-90, ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS, BY REFERENCE IN SECTION I OF THE CONTRACT.
Feb 20, 2026	P00001	$0	THE PURPOSE OF THIS MODIFICATION TO UPDATE THE BUYER FROM HAROON GULZAR TO CRAIG WRIGHT AS THE FINANCIAL SYSTEM DOES NOT ALLOW CONTRACTORS TO BE NAMED.
Jul 22, 2025	0	$106.7K	PROTEOMIC ANALYSIS OF CANCER PATIENT PLASMA SAMPLES

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

Contact	Role	Published contact methods	Evidence	Source date
Ronald Paraham	Contact	Ronald.Paraham@fda.hhs.gov	Source	Jun 6, 2025